Clinical Trials Browser

Meningioma × lutetium Lu 177 dotatate × 90 days × Clear all

NCT03971461 2026-03-11

Phase II Study of 177Lu-DOTATATE Radionuclide in Adults With Progressive or High-risk Meningioma

Phase 2 Active not recruiting

Meningioma

NCT06955169 2026-02-17

MOMENTUM-1

Phase 2 Recruiting

Meningioma